WaelAJaberMD
Cardiology • Cleveland, OHEchocardiography, Nuclear Cardiology, Non-Invasive Cardiology
Director of Nuclear Cardiology and Imaging CoreLab at C5 and Cleveland Clinic
Dr. Jaber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Summary
- Dr. Wael Jaber is a the director of Nuclear Cardiology and medical director of the imaging CoreLab in C5, and is a staff cardiologist at Cleveland Clinic. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 25 years. . He specializes in echocardiography, nuclear cardiology, valvular heart disease, ischemic cardiomyopathy, and restrictive cardiomyopathy. He has more than 400 publications and over 16000 citings. Dr Jaber is the cofounder of CardiacImagingagora.com a free space, where experts in cardiac imaging share their knowledge and experience to improve patient's care
Education & Training
Icahn School of Medicine at Mount Sinai/Morningside/BronxCareFellowship, Cardiovascular Disease, 1995 - 1998- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1992 - 1995
American University of Beirut Faculty of MedicineClass of 1992
Certifications & Licensure
OH State Medical License 1998 - 2026
NY State Medical License 1995 - 2022
FL State Medical License 2007 - 2020
IL State Medical License 2004 - 2020
MI State Medical License 2004 - 2020- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow of European Society of Cardiology ESC
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Controlled Trial of High Dietary Fiber Intake on Serum Lipids Start of enrollment: 2008 Jan 01
- The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- 23 citationsSystolic heart failure after liver transplantation: Incidence, predictors, and outcomeAbraham Sonny, Srinivasa Raghavan Govindarajan, Wael A. Jaber, Jacek B. Cywinski
Clinical Transplantation. 2018-03-01 - 92 citationsEfficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study.Wael A. Jaber, David L. Prior, Maran Thamilarasan, Richard A. Grimm, James D. Thomas
American Heart Journal. 2000-07-01 - 10 citationsPrognostic Value of Functional Capacity in Different Exercise Protocols.Serge C. Harb, Pavan Bhat, Paul Cremer, Yuping Wu, Laura J. Cremer
Journal of the American Heart Association. 2020-07-07
Journal Articles
- Original Investigation Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel ReleaseAsad Ikram, Peter J Evans, Brett W Sperry, Bryan A Reyes, Dermot Phelan, David Shapiro, Scott E Kilpatrick, E Rene Rodriguez, Wael A Jaber, Carmela D Tan, Steven Masch..., ScienceDirect
Press Mentions
Not Exercising Worse for Your Health Than Smoking, Diabetes and Heart Disease, Study RevealsJuly 30th, 2024- Endocarditis After Low-Risk TAVR: Different Trajectory, Problem OrganismsApril 30th, 2021
PARTNER: 'Reassuring' Prosthetic Aortic Valve Infection RatesNovember 6th, 2019- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
- European Society of CardiologyFellow
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
